Cooper Companies [COO] vs ResMed [RMD] Detailed Stock Comparison

The Cooper Companies Inc.

NASDAQ
Loading...

ResMed Inc.

NYSE
Loading...

TLDR: Quick Comparison Summary

Based on 21 vital metrics comparison: The Cooper Companies Inc. wins in 8 metrics, ResMed Inc. wins in 12 metrics, with 0 ties. ResMed Inc. appears stronger overall.

View Metrics Details

Vital Metrics Comparison

Metric The Cooper Companies Inc. ResMed Inc. Better
P/E Ratio (TTM) 33.48 21.69 ResMed Inc.
Price-to-Book Ratio 1.57 5.06 The Cooper Companies Inc.
Debt-to-Equity Ratio 33.20 13.41 ResMed Inc.
PEG Ratio 1.18 1.50 The Cooper Companies Inc.
EV/EBITDA 14.36 15.51 The Cooper Companies Inc.
Profit Margin (TTM) 9.67% 27.53% ResMed Inc.
Operating Margin (TTM) 20.78% 35.16% ResMed Inc.
EBITDA Margin (TTM) 20.78% 35.16% ResMed Inc.
Return on Equity 4.87% 25.68% ResMed Inc.
Return on Assets (TTM) 3.64% 14.75% ResMed Inc.
Free Cash Flow (TTM) $433.70M $1.65B ResMed Inc.
Dividend Yield N/A 0.92% N/A
1-Year Return -2.61% -21.88% The Cooper Companies Inc.
Price-to-Sales Ratio (TTM) 3.16 5.92 The Cooper Companies Inc.
Enterprise Value $15.78B $31.41B ResMed Inc.
EV/Revenue Ratio 3.80 5.82 The Cooper Companies Inc.
Gross Profit Margin (TTM) 67.88% 61.76% The Cooper Companies Inc.
Revenue per Share (TTM) $21 $37 ResMed Inc.
Earnings per Share (Diluted) $2.01 $10.12 ResMed Inc.
Beta (Stock Volatility) 1.07 0.93 ResMed Inc.
Short % of Float 3.81% 9.40% The Cooper Companies Inc.

The Cooper Companies Inc. vs ResMed Inc. Stock Performance Analysis

Loading Price Chart...

COO
RMD

Performance Comparison

Short-term Returns

Stock1D1W1M3M6MYTD
The Cooper Companies Inc.-0.18%1.45%13.67%-4.62%-16.89%-16.46%
ResMed Inc.-1.05%-0.21%-4.53%-16.42%-23.84%-21.27%

Long-term Returns

Stock1Y3Y5Y10Y15Y20Y
The Cooper Companies Inc.-2.61%-26.10%-29.28%67.73%272.56%504.45%
ResMed Inc.-21.88%-11.08%-17.97%233.76%527.92%775.81%

Performance & Financial Health Analysis: The Cooper Companies Inc. vs ResMed Inc.

MetricCOORMD
Market Information
Market Cap i$12.67B$32.03B
Market Cap CategoryLarge capLarge cap
10 Day Avg. Volume i1,772,782955,842
90 Day Avg. Volume i1,946,8771,020,554
Last Close$67.76$192.74
52 Week Range$58.89 - $89.83$180.27 - $293.81
% from 52W High-24.57%-34.40%
All-Time High$115.90 (Aug 30, 2021)$301.34 (Sep 06, 2021)
% from All-Time High-41.54%-36.04%
Growth Metrics
Quarterly Revenue Growth0.06%0.11%
Quarterly Earnings Growth0.25%0.14%
Financial Health
Profit Margin (TTM) i0.10%0.28%
Operating Margin (TTM) i0.21%0.35%
Return on Equity (TTM) i0.05%0.26%
Debt to Equity (MRQ) i33.2013.41
Cash & Liquidity
Book Value per Share (MRQ)$42.87$43.39
Cash per Share (MRQ)$0.64$9.73
Operating Cash Flow (TTM) i$866.40M$1.91B
Levered Free Cash Flow (TTM) i$367.09M$1.42B
Dividends
Last 12-Month Dividend Yield iN/A0.92%
Last 12-Month Dividend i$0.00$2.33

Valuation & Enterprise Metrics Analysis: The Cooper Companies Inc. vs ResMed Inc.

MetricCOO (Apr 24, 2026)RMD (Apr 26, 2026)
Price Ratios
P/E Ratio (TTM) i33.4821.69
Forward P/E i13.4118.02
PEG Ratio i1.181.50
Price to Sales (TTM) i3.165.92
Price to Book (MRQ) i1.575.06
Market Capitalization
Market Capitalization i$12.67B$32.03B
Enterprise Value i$15.78B$31.41B
Enterprise Value Metrics
Enterprise to Revenue i3.805.82
Enterprise to EBITDA i14.3615.51
Risk & Other Metrics
Beta i1.070.93
Book Value per Share (MRQ) i$42.87$43.39

Financial Statements Comparison: The Cooper Companies Inc. vs ResMed Inc.

Financial Metrics

Loading Financial Charts...

Revenue

Operating Margin

Profit Margin

Long Term Debt

Income Flow Analysis

Financial Statements Comparison

Income Statement

MetricCOO (2025)RMD (2025)
Revenue/Sales i4.09B5.15B
Cost of Goods Sold i1.41B2.09B
COGS % of Revenue i34.5%40.6%
Gross Profit i2.68B3.05B
Gross Margin i65.5%59.4%
Research & Development i172.20M331.28M
Operating Income (EBIT) i682.90M1.69B
Operating Margin i16.7%32.8%
EBITDA i1.05B1.93B
EBITDA Margin i25.7%37.4%
Pre-Tax Income i566.50M1.68B
Pre-Tax Income % of Revenue i13.8%32.6%
Income Tax i191.60M276.84M
Income Tax % of Revenue i4.7%5.4%
Net Income (Profit) i374.90M1.40B
Profit Margin i9.2%27.2%

Balance Sheet & Liquidity Metrics

MetricCOO (2025)RMD (2025)
Cash & Equivalents i110.60M1.21B
Total Current Assets i2.11B3.51B
Total Current Assets % of Revenue i51.5%68.1%
Total Current Liabilities i1.11B1.02B
Total Current Liabilities % of Revenue i27.2%19.8%
Long-Term Debt i2.46B811.41M
Long-Term Debt % of Revenue i60.1%15.8%
Total Shareholders Equity i8.24B5.97B
Retained Earnings i7.64B6.08B
Retained Earnings % of Revenue i186.8%118.2%
Property, Plant & Equipment i2.10M288.62M

Cash Flow Statement Comparison

MetricCOO (2025)RMD (2025)
Operating Cash Flow i742.60M1.57B
Operating Cash Flow % of Revenue i18.1%30.5%
Capital Expenditures i-362.40M-89.87M
Free Cash Flow i433.70M1.65B
FCF Margin i10.6%32.1%
Debt Repayment i-3.21B-40.00M
Common Stock Repurchase i-290.10M-300.03M

Short Interest & Institutional Ownership Analysis

MetricCOORMD
Shares Short i6.53M11.89M
Short Ratio i3.1911.24
Short % of Float i3.81%9.40%
Shares Outstanding i195.10M145.66M
Float Shares i193.68M144.79M
% Held by Insiders i0.62%0.50%
% Held by Institutions i105.72%68.82%
% Held by Public i-6.34%30.68%

Dividend Analysis & Yield Comparison: The Cooper Companies Inc. vs ResMed Inc.

MetricCOORMD
Last 12-Month Dividend i$0.00$2.33
Last 12-Month Dividend Yield iN/A0.92%
3-Year Avg Annual Dividend i$0.01$2.09
3-Year Avg Dividend Yield i0.01%0.24%
3-Year Total Dividends i$0.03$6.28
Ex-Dividend DateJul 26, 2023Feb 12, 2026